Syros Pharmaceuticals Inc (SYRS)
5.13
-0.08
(-1.54%)
USD |
NASDAQ |
May 03, 16:00
5.13
0.00 (0.00%)
After-Hours: 18:54
Syros Pharmaceuticals Profit Margin (Quarterly): -16.68K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.68K% |
| September 30, 2023 | -1.07K% |
| June 30, 2023 | -1.28K% |
| March 31, 2023 | -805.3% |
| December 31, 2022 | |
| September 30, 2022 | -777.5% |
| June 30, 2022 | -549.4% |
| March 31, 2022 | -460.0% |
| December 31, 2021 | -305.2% |
| September 30, 2021 | -456.9% |
| June 30, 2021 | -435.7% |
| March 31, 2021 | -294.8% |
| December 31, 2020 | -528.7% |
| September 30, 2020 | -509.0% |
| June 30, 2020 | -539.4% |
| March 31, 2020 | -724.1% |
| December 31, 2019 | -3.88K% |
| September 30, 2019 | -3.55K% |
| Date | Value |
|---|---|
| June 30, 2019 | -4.21K% |
| March 31, 2019 | -3.63K% |
| December 31, 2018 | -2.02K% |
| September 30, 2018 | -3.82K% |
| June 30, 2018 | -3.75K% |
| March 31, 2018 | -3.91K% |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | -1.05K% |
| December 31, 2016 | -3.46K% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | -1.92K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-16.68K%
Minimum
Dec 2023
-294.8%
Maximum
Mar 2021
-2.06K%
Average
-636.7%
Median
Profit Margin (Quarterly) Benchmarks
| PDS Biotechnology Corp | -- |
| PAVmed Inc | -1.34K% |
| Moderna Inc | 7.71% |
| Altimmune Inc | -85.52K% |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -228.1% |
| Return on Assets | -86.91% |
| Return on Invested Capital | -145.6% |
| Operating Margin (Quarterly) | -7.00K% |
| Return on Net Operating Assets | -696.8% |